Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	727-729
Number of pages	3
Journal	Clinical advances in hematology & oncology : H&O
Volume	6
Issue number	10
State	Published - Oct 2008

ASJC Scopus subject areas

@article{b4fa036f93eb4d6ebb7b2681b024d440,

title = "Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.",

author = "Kay, {Neil E.}",

year = "2008",

month = oct,

language = "English (US)",

volume = "6",

pages = "727--729",

journal = "Clinical advances in hematology & oncology : H&O",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "10",

}

TY - JOUR

T1 - Benefits of minimal residual disease negativity in the therapy of chronic lymphocytic leukemia.

AU - Kay, Neil E.

PY - 2008/10

Y1 - 2008/10

UR - http://www.scopus.com/inward/record.url?scp=58149231515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149231515&partnerID=8YFLogxK

M3 - Article

C2 - 18997661

AN - SCOPUS:58149231515

SN - 1543-0790

VL - 6

SP - 727

EP - 729

JO - Clinical advances in hematology & oncology : H&O

JF - Clinical advances in hematology & oncology : H&O

IS - 10

ER -